| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $28.5M | +109.6% |
| SG&A Expense | $108.1M | +0.7% |
| Operating Income | -$143.0M | -16.7% |
| Pre-tax Income | -$72.4M | +26.9% |
| Income Tax | $670K | — |
| Net Income | -$71.9M | +27.2% |
| EPS (Basic) | -$0.51 | +38.6% |
| EPS (Diluted) | -$0.51 | +38.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $253.3M | -42.8% |
| Current Assets | $312.0M | -46.2% |
| Total Assets | $732.2M | -11.5% |
| Current Liabilities | $49.2M | -21.4% |
| Total Liabilities | $97.5M | -9.4% |
| Stockholders' Equity | $633.2M | -11.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.9M | +2.3% |
| Capital Expenditures | $187.8M | +3.9% |
| Investing Cash Flow | -$187.0M | -6.8% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$275.8M | -1.8% |